Earnest Partners (CLB) discloses 6.9% Core Laboratories ownership

Rhea-AI Filing Summary

EARNEST Partners, LLC reported beneficial ownership of 3,221,043 shares of Core Laboratories Inc. common stock, representing 6.9% of the class as of 12/31/2025. The firm has sole voting power over 2,026,540 shares and shared voting power over 298,965 shares.

EARNEST Partners also has sole dispositive power over all 3,221,043 shares and no shared dispositive power. It is filing as an investment adviser and states that no individual client owns more than five percent of the class. The position is certified as held in the ordinary course of business and not for the purpose of changing or influencing control of Core Laboratories.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 12)

Core Laboratories Inc. /DE/

(Name of Issuer)

Common Stock

(Title of Class of Securities)

21867A105

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 21867A105

1

Names of Reporting Persons

EARNEST PARTNERS LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,026,540.00
6	Shared Voting Power 298,965.00
7	Sole Dispositive Power 3,221,043.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,221,043.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Core Laboratories Inc. /DE/
(b)	Address of issuer's principal executive offices: 6316 WINDFERN ROAD, HOUSTON, TEXAS, 77040.
Item 2.
(a)	Name of person filing: EARNEST Partners, LLC
(b)	Address or principal business office or, if none, residence: 1180 Peachtree Street NE Suite 2300 Atlanta, GA 30309
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 21867A105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,221,043.00
(b)	Percent of class: 6.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,026,540.00
	(ii) Shared power to vote or to direct the vote: 298,965.00
	(iii) Sole power to dispose or to direct the disposition of: 3,221,043.00
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. EARNEST Partners, LLC is filing as an investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). No client interest relates to more than five percent of the class.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

EARNEST PARTNERS LLC

Signature:	James M. Wilson
Name/Title:	Chief Compliance Officer
Date:	02/12/2026

FAQ

What ownership stake in Core Laboratories (CLB) did EARNEST Partners report?

EARNEST Partners reported beneficial ownership of 3,221,043 Core Laboratories shares, representing 6.9% of the common stock. This makes the firm a significant institutional holder, with the filing reflecting its position as of December 31, 2025.

How much voting power does EARNEST Partners have in Core Laboratories (CLB)?

EARNEST Partners has sole voting power over 2,026,540 Core Laboratories shares and shared voting power over 298,965 shares. Overall, it can vote or direct the vote on a substantial portion of its 3,221,043-share beneficial position.

What type of filer is EARNEST Partners in this Core Laboratories (CLB) Schedule 13G/A?

EARNEST Partners is filing as an investment adviser under Rule 13d-1(b)(1)(ii)(E). This means it reports holdings it manages for clients, rather than proprietary positions alone, consistent with its role as an institutional asset manager.

Are any EARNEST Partners clients above 5% ownership in Core Laboratories (CLB)?

No. The filing states that no client interest relates to more than five percent of the Core Laboratories common stock class. The 6.9% aggregate stake reflects shares managed across multiple clients, none individually exceeding the 5% threshold.

Is EARNEST Partners seeking to influence control of Core Laboratories (CLB)?

The filing certifies the securities were acquired and are held in the ordinary course of business, not for changing or influencing control of Core Laboratories. It also notes they are not held in connection with any control-related transaction or activist nomination.

What dispositive power does EARNEST Partners report over Core Laboratories (CLB) shares?

EARNEST Partners reports sole dispositive power over all 3,221,043 Core Laboratories shares and no shared dispositive power. This means it can decide how and when to dispose of these shares on behalf of its clients, consistent with advisory agreements.